NLRP3 and hyperlipidemia: Furthermore, hyperlipidemia may induce NLRP3 inflammasome activation in immune cells and produce large amounts of IL-1β, leading to phenotype transformation of VSMCs and synthesis and secretion of MMPs stimulated by IL-1β produced after immune cell infiltration [11].